Company intelligence / Profile preview

Truverra

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Truverra operates commercially, producing and marketing cannabis and hemp‑derived medicinal products, including a portfolio of CBD supplements and medical devices in Europe via Truverra (Europe) B.V., and providing GMP extraction and purification services through Canadian Clinical Cannabinoids in Canada. No formal clinical‑trial results are disclosed in available sources.

Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

Relationship with Supreme Cannabis Company as sole shareholder/parent; no major external pharma/biotech partnerships identified beyond this corporate group.

Beyond the preview

Go deeper on Truverra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Truverra.

Explore the full profile